Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor.
Orengo AM, Fabbi M, Miglietta L, Andreani C, Bruzzone M, Puppo A, Cristoforoni P, Centurioni MG, Gualco M, Salvi S, Boccardo S, Truini M, Piazza T, Canevari S, Mezzanzanica D, Ferrini S.
Orengo AM, et al. Among authors: cristoforoni p.
Int J Cancer. 2011 Sep 1;129(5):1116-25. doi: 10.1002/ijc.25757. Epub 2011 Jan 6.
Int J Cancer. 2011.
PMID: 21710494